Insider · CIK 0001710237

Feder Julie B

Reports to the SEC for 3 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001710237

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-10-18	AURAAura Biosciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+5,000 sh	$5.48	+$27.4K	159,407
2024-10-18	AURAAura Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−5,000 sh	—	—	120,547
2024-10-18	AURAAura Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−2,631 sh	—	—	32,359
2024-10-18	AURAAura Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−17.5K sh	—	—	68,257
2024-10-18	AURAAura Biosciences, Inc.S Sale	Chief Financial Officer	SSale	−25.1K sh	$12.03	−$302K	134,276
2024-10-18	AURAAura Biosciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+17.5K sh	$2.74	+$48K	151,776
2024-10-18	AURAAura Biosciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+2,631 sh	$4.25	+$11.2K	154,407
2024-02-01	AURAAura Biosciences, Inc.A Award	Chief Financial Officer	AAward	+71.3K sh	—	—	134,276
2024-02-01	AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+104K sh	—	—	103,715
2024-01-23	AURAAura Biosciences, Inc.S Sale	Chief Financial Officer	SSale	−6,609 sh	$7.64	−$50.5K	62,991
2023-11-06	AURAAura Biosciences, Inc.S Sale	Chief Financial Officer	SSale	−3,900 sh	$12.07	−$47.1K	69,600
2023-11-06	AURAAura Biosciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+3,900 sh	$2.74	+$10.7K	73,500
2023-11-06	AURAAura Biosciences, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−3,900 sh	—	—	85,757
2023-10-30	AURAAura Biosciences, Inc.S Sale	Chief Financial Officer	SSale	−3,385 sh	$6.82	−$23.1K	69,600
2023-01-19	AURAAura Biosciences, Inc.A Award	Chief Financial Officer	AAward	+48.8K sh	—	—	72,985
2023-01-19	AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2022-10-31	AURAAura Biosciences, Inc.S Sale	Chief Financial Officer	SSale	−2,015 sh	$12.45	−$25.1K	24,235
2021-10-28	AURAAura Biosciences, Inc.A Award	Chief Financial Officer	AAward	+26.3K sh	—	—	26,250
2021-10-28	AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+113K sh	—	—	112,500
2018-04-06	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+5,000 sh	—	—	5,000
2017-07-10	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+370K sh	—	—	370,000

Recent filings

Accepted (ET)
Oct 214
Feder Julie B0000950170-24-116029
SEC(opens sec.gov)
Feb 24
Feder Julie B0000950170-24-010462
SEC(opens sec.gov)
Jan 244
Feder Julie B0000950170-24-006987
SEC(opens sec.gov)
Nov 74
Feder Julie B0000950170-23-060493
SEC(opens sec.gov)
Nov 14
Feder Julie B0000950170-23-057643
SEC(opens sec.gov)
Jan 234
Feder Julie B0000899243-23-002437
SEC(opens sec.gov)
Nov 24
Feder Julie B0000899243-22-034838
SEC(opens sec.gov)
Oct 294
Feder Julie B0000899243-21-042083
SEC(opens sec.gov)
Jun 44
Feder Julie B0001104659-18-038052
SEC(opens sec.gov)

Companies

Address

OBSIDIAN THERAPEUTICS, INC. 1030 MASSACHUSETTS AVE

CAMBRIDGE, MA, 02138